Medical News

The use of biologic agents for the therapy of inflammatory bowel disease (IBD) may benefit patients, but doctors need to consider the potential associated side effects in determining therapy course, as per a consensus paper published in this months issue of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. IBD includes Crohns disease and ulcerative colitis, both frequently disabling diseases that affect approximately one million people both in the U.S. and Europe……..

Original post by Health news from medicineworld.org

The use of biologic agents for the therapy of inflammatory bowel disease (IBD) may benefit patients, but doctors need to consider the potential associated side effects in determining therapy course, as per a consensus paper published in this months issue of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. IBD includes Crohns disease and ulcerative colitis, both frequently disabling diseases that affect approximately one million people both in the U.S. and Europe……..

Original post by Health news from medicineworld.org